A look at MRNA’s current quarter earnings estimates

In the current trading session, Moderna Inc’s (MRNA) stock is trading at the price of $23.55, a fall of -2.06% over last night’s close. So, the stock is trading at a price that is -70.54% less than its 52-week high of $79.96 and 1.74% better than its 52-week low of $23.15. Based on the past 30-day period, the stock price is -17.03% below the high and +1.45% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, MRNA’s SMA-200 is $32.05.

It is also essential to consider MRNA stock ratios like the price-to-sales ratio, which is 2.98 for the last year.MRNA’s price to book ratio for the most recent quarter was 0.97, resulting in an 1.79 price to cash per share for the period.

How does Moderna Inc (MRNA) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 27 brokerage firms that recommend the stock as a Hold. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 2.96 in simple terms.

Moderna Inc (MRNA): Earnings History

If we examine Moderna Inc’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$2.13, slashing the consensus of -$2.97. In other words, it beat the consensus by $0.84, resulting in a 28.28% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$2.13 in contrast with the Outlook of -$2.97. That was a difference of $0.84 and a surprise of 28.28%.

Moderna Inc (MRNA): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 11 different analysts, who are expecting earnings to fall in between the range of -0.75 and -2.68 with an average Earnings Estimate of -1.94 which is in contrast with the last year earnings estimate of 0.03 and also replicates -6,566.67% growth rate year over year.

Moderna Inc (NASDAQ: MRNA) Ownership Details

I will give a breakdown of the key shareholders in Moderna Inc (MRNA). Recent figures show that the company’s insiders hold 7.24% of shares. A total of 1,025 institutional investors hold shares in the company, making 74.90% of its stock and 80.75% of its float.

Jun 30, 2025, it was reported that the Company’s largest institutional holder is VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holding total of 11.19 shares that make 2.88% of the company’s total number of shares and are currently priced at 265.37 million.

The securities firm VANGUARD INDEX FUNDS-Vanguard 500 Index Fund holds 9.66 shares of MRNA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 2.48%, and the holding percentage of shares is valued at 229.07 million.

An overview of Moderna Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Moderna Inc (MRNA) traded 9,073,120 shares per day, with a moving average of $25.87 and price change of -2.99. With the moving average of $28.87 and a price change of -3.08, about 9,201,412 shares changed hands on average over the past 50 days. Finally, MRNA’s 100-day average volume is 9,965,180 shares, alongside a moving average of $27.60 and a price change of -0.78.

Hot this week

What Are the Chances of B2gold Corp (BTG) Stagnating? Here is the INSIGHT

B2gold Corp (BTG)'s stock is trading at $4.03 at...

Do you want to know where to find good stock? Take a look at APA Corporation’s (NASDAQ:APA) Sentiment Analysis

APA Corporation (APA)'s stock has witnessed a price hike...

What is going on with James Hardie Industries plc? Sentiment Analysis

Currently, James Hardie Industries plc's (JHX) stock is trading...

You Should Read This Analysis Before Investing in Celsius Holdings Inc (NASDAQ:CELH)

In the current trading session, Celsius Holdings Inc's (CELH)...

Cameco Corp (NYSE:CCJ): It’s all about numbers this morning

Cameco Corp (CCJ)'s stock is trading at $76.07 at...

Topics

What Are the Chances of B2gold Corp (BTG) Stagnating? Here is the INSIGHT

B2gold Corp (BTG)'s stock is trading at $4.03 at...

What is going on with James Hardie Industries plc? Sentiment Analysis

Currently, James Hardie Industries plc's (JHX) stock is trading...

You Should Read This Analysis Before Investing in Celsius Holdings Inc (NASDAQ:CELH)

In the current trading session, Celsius Holdings Inc's (CELH)...

Cameco Corp (NYSE:CCJ): It’s all about numbers this morning

Cameco Corp (CCJ)'s stock is trading at $76.07 at...

Pure Storage Inc (NYSE:PSTG) stock: Is this a flash in the pan today?

Pure Storage Inc (PSTG)'s stock has witnessed a price...

Clearwater Analytics Holdings Inc (NYSE:CWAN) stock crossing the finish line today

Currently, Clearwater Analytics Holdings Inc's (CWAN) stock is trading...

Today’s watch list includes Datadog Inc (NASDAQ:DDOG) stock

In the current trading session, Datadog Inc's (DDOG) stock...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.